The American Society of Clinical Oncology has published a new clinical practice guideline on the use of cannabis and cannabinoids in people with cancer. In this podcast, Ilana Braun, MD, FACLP, and Eric Roeland, MD, FAAHPM, FASCO, who served as co-chairs of this guideline, discuss what people with cancer should know about using cannabis and cannabinoids, including what the guideline recommends and the importance of discussing the use of these products with your health care team.
-
What is a clinical practice guideline, and how does it help guide cancer care? [2:05]
-
What are cannabis and cannabinoids? [4:07]
-
Why do people with cancer often choose to use cannabis and cannabinoids? [5:18]
-
Why is it important for people with cancer to talk with their health care team if they are using or thinking about using cannabis or cannabinoids? [9:12]
-
What are ASCO’s recommendations on using cannabis and cannabinoids during cancer? [17:26]
-
Why does the guideline recommend using cannabis and cannabinoids mostly in clinical trials? [19:32]
-
What should caregivers know about cannabis and cannabinoids? [23:13]
Dr. Braun is an assistant professor of psychiatry at Harvard Medical School and chief of the Division of Adult Psychosocial Oncology at the Dana-Farber Cancer Institute. Dr. Roeland is an associate professor of medicine at Oregon Health & Science University. View disclosure information for Dr. Braun and Dr. Roeland.
Was this podcast useful? Please subscribe, rate, and review Cancer.Net Podcasts wherever you listen to podcasts. This prerecorded podcast can be listened to online or downloaded to your computer. A transcript is also available. For more information, visit the Cancer.Net podcast page.
Cancer.Net podcasts are edited for length and content.
